GlaxoSmithKline PLC Director/PDMR Shareholding (9957Y)
20 January 2022 - 2:10AM
UK Regulatory
TIDMGSK
RNS Number : 9957Y
GlaxoSmithKline PLC
19 January 2022
GlaxoSmithKline plc (the ' Company ')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
==== ============================================================================================
a) Name Ms E Walmsley
==== ====================================== ====================================================
b) Position/status Chief Executive Officer
==== ====================================== ====================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ============================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ====================================== ====================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 13 January 2022
on Ordinary Shares held in the Company's
Deferred Annual Bonus Plan
==== ====================================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================== ======================
GBP16.3120 832
=========================================== ========================== ======================
GBP16.3120 669
========================== ======================
GBP16.3120 557
========================== ======================
d) Aggregated information 2,058
====
Aggregated volume GBP16.3120
Price
=========================================== ====================================================
e) Date of the transaction 2022-01-17
==== ====================================== ====================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ============================================================================================
a) Name Mr I Mackay
==== ====================================== ====================================================
b) Position/status Chief Financial Officer
==== ====================================== ====================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ============================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ====================================== ====================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 13 January 2022
on Ordinary Shares held in the Company's
Deferred Annual Bonus Plan
==== ====================================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================== ======================
GBP16.3120 452
=========================================== ========================== ======================
GBP16.3120 386
========================== ======================
d) Aggregated information 838
====
Aggregated volume GBP16.3120
Price
=========================================== ====================================================
e) Date of the transaction 2022-01-17
==== ====================================== ====================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ============================================================================================
a) Name Dr H Barron
==== ======================================= ===================================================
b) Position/status Chief Scientific Officer and President,
R&D
==== ======================================= ===================================================
c) Initial notification/ Initial notification
amendment
==== ======================================= ===================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================= ===================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================= ===================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ============================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
==== ======================================= ===================================================
b) Nature of the Increase in notional interest in ADSs following
transaction the re-investment of dividends paid to
shareholders on 13 January 2022 on ADSs
held in the Company's Deferred Annual Bonus
Plan
==== ======================================= ===================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================= ========================= ======================
$ 45.0600 483
============================================ ========================= ======================
$ 45.0600 379
========================= ======================
$ 45.0600 287
========================= ======================
d) Aggregated information 1,149
====
Aggregated volume $ 45.0600
Price
============================================ ===================================================
e) Date of the transaction 2022-01-17
==== ======================================= ===================================================
f) Place of the New York Stock Exchange (XNYS)
transaction
==== ======================================= ===================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ============================================================================================
a) Name Mr R Connor
==== ====================================== ====================================================
b) Position/status President, Vaccines & Global Health
==== ====================================== ====================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ============================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ====================================== ====================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 13 January 2022
on Ordinary Shares held in the Company's
Deferred Annual Bonus Plan
==== ====================================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================== ======================
GBP16.3120 218
=========================================== ========================== ======================
GBP16.3120 211
========================== ======================
GBP16.3120 122
========================== ======================
d) Aggregated information 551
====
Aggregated volume GBP16.3120
Price
=========================================== ====================================================
e) Date of the transaction 2022-01-17
==== ====================================== ====================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ============================================================================================
a) Name Ms D Conrad
==== ====================================== ====================================================
b) Position/status SVP Human Resources
==== ====================================== ====================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ============================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ====================================== ====================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 13 January 2022
on Ordinary Shares held in the Company's
Deferred Annual Bonus Plan
==== ====================================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================== ======================
GBP16.3120 87
=========================================== ========================== ======================
GBP16.3120 80
========================== ======================
d) Aggregated information 167
====
Aggregated volume GBP16.3120
Price
=========================================== ====================================================
e) Date of the transaction 2022-01-17
==== ====================================== ====================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ============================================================================================
a) Name Mr J Ford
==== ====================================== ====================================================
b) Position/status Senior Vice President and General Counsel
==== ====================================== ====================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ============================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ====================================== ====================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 13 January 2022
on Ordinary Shares held in the Company's
Deferred Annual Bonus Plan
==== ====================================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================== ======================
GBP16.3120 124
=========================================== ========================== ======================
GBP16.3120 97
========================== ======================
d) Aggregated information 221
====
Aggregated volume GBP16.3120
Price
=========================================== ====================================================
e) Date of the transaction 2022-01-17
==== ====================================== ====================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== =============================================================================================
a) Name Mr J Ford
==== ======================================= ====================================================
b) Position/status Senior Vice President and General Counsel
==== ======================================= ====================================================
c) Initial notification/ Initial notification
amendment
==== ======================================= ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================= ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================= ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =============================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
==== ======================================= ====================================================
b) Nature of the Increase in notional interest in ADSs following
transaction the re-investment of dividends paid to
shareholders on 13 January 2022 on ADSs
held in the Company's Deferred Annual Bonus
Plan
==== ======================================= ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================= ========================= ======================
$ 45.0600 41
========================= ======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
======================================== ========================================================
e) Date of the transaction 2022-01-17
==== ======================================= ====================================================
f) Place of the New York Stock Exchange (XNYS)
transaction
==== ======================================= ====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ===========================================================================================
a) Name Ms S Jackson
==== ===================================== ====================================================
b) Position/status SVP, Global Communications & CEO Office
==== ===================================== ====================================================
c) Initial notification/ Initial notification
amendment
==== ===================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===========================================================================================
a) Name GlaxoSmithKline plc
==== ===================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ===================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ===================================== ====================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 13 January 2022
on Ordinary Shares held in the Company's
Deferred Annual Bonus Plan
==== ===================================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ===================================== =========================== =====================
GBP 16.3120 52
========================================== =========================== =====================
GBP 16.3120 49
=========================== =====================
d) Aggregated information 101
====
Aggregated volume GBP 16.3120
Price
========================================== ====================================================
e) Date of the transaction 2022-01-17
==== ===================================== ====================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ===================================== ====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ============================================================================================
a) Name Mr B McNamara
==== ======================================= ===================================================
b) Position/status CEO, GSK Consumer Healthcare
==== ======================================= ===================================================
c) Initial notification/ Initial notification
amendment
==== ======================================= ===================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================= ===================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================= ===================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ============================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
==== ======================================= ===================================================
b) Nature of the Increase in notional interest in ADSs following
transaction the re-investment of dividends paid to
shareholders on 13 January 2022 on ADSs
held in the Company's Deferred Annual Bonus
Plan
==== ======================================= ===================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== --------------------------------------- ========================= ======================
$ 45.0600 81
-------------------------------------------- ========================= ======================
$ 45.0600 69
========================= ======================
$ 45.0600 87
------------------------- ----------------------
d) Aggregated information 237
====
Aggregated volume $ 45.0600
Price
============================================ ===================================================
e) Date of the transaction 2022-01-17
==== ======================================= ===================================================
f) Place of the New York Stock Exchange (XNYS)
transaction
==== ======================================= ===================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ============================================================================================
a) Name Mr L Miels
==== ====================================== ====================================================
b) Position/status Chief Commercial Officer
==== ====================================== ====================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ============================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ====================================== ====================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 13 January 2022
on Ordinary Shares held in the Company's
Deferred Annual Bonus Plan
==== ====================================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================== ======================
GBP16.3120 232
=========================================== ========================== ======================
GBP16.3120 202
========================== ======================
GBP16.3120 151
========================== ======================
d) Aggregated information 585
====
Aggregated volume GBP16.3120
Price
=========================================== ====================================================
e) Date of the transaction 2022-01-17
==== ====================================== ====================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ============================================================================================
a) Name Mr D Redfern
==== ====================================== ====================================================
b) Position/status Chief Strategy Officer
==== ====================================== ====================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ============================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ====================================== ====================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 13 January 2022
on Ordinary Shares held in the Company's
Deferred Annual Bonus Plan
==== ====================================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================== ======================
GBP16.3120 206
=========================================== ========================== ======================
GBP16.3120 148
========================== ======================
GBP16.3120 118
========================== ======================
d) Aggregated information 472
====
Aggregated volume GBP16.3120
Price
=========================================== ====================================================
e) Date of the transaction 2022-01-17
==== ====================================== ====================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ============================================================================================
a) Name Mr R Simard
==== ====================================== ====================================================
b) Position/status President, Pharmaceuticals Supply Chain
==== ====================================== ====================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ============================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ====================================== ====================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 13 January 2022
on Ordinary Shares held in the Company's
Deferred Annual Bonus Plan
==== ====================================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================== ======================
GBP16.3120 74
=========================================== ========================== ======================
GBP16.3120 105
========================== ======================
GBP16.3120 89
========================== ======================
d) Aggregated information 268
====
Aggregated volume GBP16.3120
Price
=========================================== ====================================================
e) Date of the transaction 2022-01-17
==== ====================================== ====================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ============================================================================================
a) Name Mr P Thomson
==== ====================================== ====================================================
b) Position/status President, Global Affairs
==== ====================================== ====================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ============================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ====================================== ====================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 13 January 2022
on Ordinary Shares held in the Company's
Deferred Annual Bonus Plan
==== ====================================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================== ======================
GBP16.3120 120
=========================================== ========================== ======================
GBP16.3120 85
========================== ======================
GBP16.3120 69
========================== ======================
d) Aggregated information 274
====
Aggregated volume GBP16.3120
Price
=========================================== ====================================================
e) Date of the transaction 2022-01-17
==== ====================================== ====================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ==============================================================================================
a) Name Ms D Waterhouse
==== ====================================== ======================================================
b) Position/status Chief Executive Officer of ViiV Healthcare
==== ====================================== ======================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ======================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ======================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ======================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ====================================== ======================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 13 January 2022
on Ordinary Shares held in the Company's
Deferred Annual Bonus Plan
==== ====================================== ======================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== =========================== ======================
GBP16.3120 142
======================================================================= ======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
==================================================================== =============================
e) Date of the transaction 2022-01-17
==== ====================================== ======================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ======================================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHEKLFFLFLBBBQ
(END) Dow Jones Newswires
January 19, 2022 10:10 ET (15:10 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024
